SELECT TRIAL: Semaglutide, Central Fat, and Cardioprotection 🧪🏹🛡️

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC

🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs. 👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3 #SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet

Episode metadata supplied by the publisher feed · Published Oct 24, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

SELECT TRIAL: Semaglutide, Central Fat, and Cardioprotection 🧪🏹🛡️

0:00 6:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 6 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on October 24, 2025.

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!